AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 
Apple Restores Telegram to App Store After Content Policy Violation 
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation 
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves 
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race 
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover 
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal 
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership 
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel 
VELDHOVEN, the Netherlands - ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program.
| Date | Total repurchased shares | Weighted average price | Total repurchased value |
| 26-Mar-18 | 50,000 | 163.83 | 8,191,513.70 |
| 27-Mar-18 | - | - | - |
| 28-Mar-18 | 20,000 | 157.39 | 3,147,878.00 |
| 29-Mar-18 | - | - | - |
ASML's current share buyback program was announced on 17 January 2018, and details are available on our website at https://www.asml.com/investors/share-buyback/en/s25436
This regular update of the transactions conducted under the buyback program is to be made public under the Market Abuse Regulation (Nr. 596/2014).
| Media Relations Contacts | Investor Relations Contacts |
| Monique Mols, phone +31 6 528 444 18 | Skip Miller, phone +1 480 235 0934 |
| Niclas Mika, phone +31 6 201 528 63 | Marcel Kemp, phone +31 40 268 6494 |
